In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Edwards Lifesciences and Dexcom Join Forces in New Critical Care Growth Market

Executive Summary

A new market in hospital intensive care units has opened up for companies glucose monitoring technologies and it represents a double-digit growth opportunity both for companies with continuous glucose monitors and critical care franchises. As partners,, Edwards Lifesciences and Dexcom bring both the marketing and technological strengths to successfully compete in this new market.
Advertisement

Related Content

Tight Glycemic Control: Critical Care’s Balancing Act
Tight Glycemic Control: Critical Care’s Balancing Act
Recent Trends in Hemodynamic Monitoring
The Top Device Stories of 2008
Continuous Glucose Monitoring: A Revolution Powered by DexCom
Continuous Glucose Monitoring: A Revolution Powered by DexCom
GlucoLight Makes Non-Invasive Glucose Monitoring Real
GlucoLight Makes Non-Invasive Glucose Monitoring Real
Devices for a Diabetes Epidemic
Luminous Medical Inc.

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV003047

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel